Table 1.
Primary Outcomes |
1. Worst-ever LVEF |
2. Worst-ever maximum z-score of the proximal LAD or RCA |
Secondary Cardiac Outcomes |
1. Occurrence of a proximal LAD or RCA z-score of ≥2.5 on any echocardiogram |
2. Occurrence of aneurysms by Japanese Ministry of Health criteria |
3. Individual z-scores for the LMCA, RCA, and LAD |
4. Left ventricular size and function: LVEDV z-score, LVEF, LVSF |
5. Percentage of patients who had LVEF <55% on any echocardiogram |
a. LVEF 45–54% (mildly depressed systolic function) |
b. LVEF 35–44% (moderately depressed systolic function) |
c. LVEF <35% (severely depressed systolic function |
6. LV strain |
a. Global longitudinal strain from apical view |
b. Global circumferential strain from parasternal short-axis view |
7. Right ventricular systolic function (qualitative assessment) |
a. If possible, right ventricular global longitudinal strain |
8. Presence and degree of mitral and aortic valve insufficiency |
9. LV diastolic function, i.e., tissue Doppler imaging and mitral valve inflow |
10. Presence and size of pericardial effusion |
11. The occurrence of arrhythmias and conduction system disturbances |
12. Exercise testing (age and maturing permitting) at ~3 months in those who had at least moderate systolic dysfunction |
13. CMR outcomes |
a. LVEF and RVEF |
b. Valvar regurgitation |
c. Percent of participants with |
i. Myocardial late gadolinium enhancement, and its distribution |
ii. Abnormal LV T2-weighted imaging |
iii. Elevated LV T2 |
iv. Elevated LV native T1 |
v. Elevated LV extracellular volume fraction |
vi. Coronary artery dilation |
vii. Final interpretation of CMR as abnormal, equivocal, or normal |
LVEF=Left ventricular ejection fraction; LAD=Left anterior descending; RCA=Right coronary artery; LMCA=Left main coronary artery; LVEDV=Left ventricular end-diastolic volume; LVSF=Left ventricular shortening fraction; CMR=Cardiac magnetic resonance imaging; RVEF=Right ventricular ejection fraction